Ryan Pepiot's Season Is Over: What Hip Surgery Means for the Rays' Rotation and Run Environment

Per the team's announcement, manager Kevin Cash confirmed Friday that right-hander Ryan Pepiot will undergo season-ending hip surgery on May 13, performed by Dr. Thomas Byrd in Nashville. Pepiot never threw a meaningful pitch in 2025 — he's been shelved since Spring Training with right hip inflammation, landed on the 15-day IL on March 25, and was bumped to the 60-day IL on April 14 after a late April throwing session left him feeling 'unstable' even playing catch at 60 feet. The surgery closes the book on any comeback attempt. He's expected to be ready for Spring Training 2026.

Pepiot wasn't just a depth piece — he was Tampa Bay's projected ace entering this season. Over the previous two years combined, he posted a 3.75 ERA across 297 2/3 innings and 57 starts, delivering genuine frontline value on a roster built around pitching efficiency. His absence forced the Rays to pivot to Joe Boyle on Opening Day, and then Boyle went down too, leaving the organization scrambling. Jesse Scholtens has absorbed the bulk-innings role out of necessity, not design.

With Scholtens serving as a stopgap and Griffin Jax — who worked 2 1/3 innings as an opener last Sunday — now being floated as a rotation option, Tampa Bay's starting pitching is held together with tape. Jax is scheduled to start Saturday against the Giants at Tropicana Field. That's a meaningful step down in profile from a pitcher who logged nearly 300 innings at a 3.75 clip over two seasons. The Rays' vaunted pitching infrastructure is being stress-tested in real time.

For bettors, this rotation instability has direct implications for Tampa Bay team totals and first-five-inning lines. Scholtens and Jax aren't high-strikeout arms — they're innings-eaters tasked with limiting damage, not missing bats. Opposing offenses facing a Rays opener/bulk combo should see elevated run expectations compared to a Pepiot start. Tampa Bay's team total also deserves scrutiny: a thin rotation that can't carry deep into games leans harder on a bullpen that will fatigue over a long season. Watch for spots where TB is a home underdog with a non-ace arm on the mound — those team totals are worth pressing over.

The strikeout prop market is where the sharpest edge lives in the near term. Jax and Scholtens simply don't generate the swing-and-miss volume that Pepiot did. Any opponent starter facing this Rays lineup with a credible K rate becomes more attractive on the over, and Rays pitcher strikeout props on nights with Scholtens or Jax starting should be faded hard. Until Tampa Bay stabilizes its rotation with a legitimate arm, treat every TB starting pitching line with skepticism.